Revolution Medicines (RVMD) Return on Capital Employed: 2020-2025
Historic Return on Capital Employed for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to -0.49%.
- Revolution Medicines' Return on Capital Employed fell 10.00% to -0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.49%, marking a year-over-year decrease of 10.00%. This contributed to the annual value of -0.32% for FY2024, which is 6.00% up from last year.
- Per Revolution Medicines' latest filing, its Return on Capital Employed stood at -0.49% for Q3 2025, which was down 22.05% from -0.41% recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' Return on Capital Employed registered a high of -0.19% during Q2 2021, and its lowest value of -0.49% during Q3 2025.
- Its 3-year average for Return on Capital Employed is -0.36%, with a median of -0.35% in 2024.
- Per our database at Business Quant, Revolution Medicines' Return on Capital Employed decreased by 19bps in 2022 and then climbed by 6bps in 2023.
- Quarterly analysis of 5 years shows Revolution Medicines' Return on Capital Employed stood at -0.28% in 2021, then dropped by 6bps to -0.34% in 2022, then decreased by 1bps to -0.35% in 2023, then increased by 1bps to -0.35% in 2024, then declined by 10bps to -0.49% in 2025.
- Its last three reported values are -0.49% in Q3 2025, -0.41% for Q2 2025, and -0.34% during Q1 2025.